HALB News and Press, Tykhe Corp From 02/22/22

JACKSON CENTER, PA / ACCESSWIRE / February 22, 2022 / Halberd Corporation (OTC PINK:HALB) has made a medical breakthrough in the treatment of neurodegenerative diseases. With the successful elimination of glutamate from cerebral spinal fluid (CSF), Halberd has demonstrated the capability t...

Tau buildup in the brain is linked to Alzheimer's and other neurodegenerative diseases. JACKSON CENTER, PA / ACCESSWIRE / February 8, 2022 / Halberd Corporation (OTC PINK:HALB) has demonstrated the ability to eliminate 100% of Tau protein from cerebral spinal fluid (CSF) in less than ...

Tau has been shown to be important in the development of Alzheimer's Disease. Eradication of Tau accomplished without reducing levels of non-target cytokine. JACKSON CENTER, PA / ACCESSWIRE / February 1, 2022 / Halberd Corporation (OTC PINK:HALB) has demonstrated the ability to s...

Jackson Center, Pennsylvania--(Newsfile Corp. - January 25, 2022) - Greetings From The CEO And Staff At HALBERD CORPORATION   (OTC Pink: HALB) ! First of all, I want to wish all of our shareholders and constituents a Very Healthy, Happy and Prosperous New Year! 2021 O...

JACKSON CENTER, PA / ACCESSWIRE / January 25, 2022 / Greetings From The CEO And Staff At HALBERD CORPORATION ! (OTC PINK:HALB) First of all I want to wish all of our shareholders and constituents a Very Healthy, Happy and Prosperous New Year! 2021 OVERVIEW AND ACHIEVEMENTS Halberd...

JACKSON CENTER, PA / ACCESSWIRE / January 13, 2022 / Halberd, Inc. (OTC PINK:HALB) ("HALB" or the "Company"), an innovative biotech company focused on developing treatments for difficult-to-cure debilitating diseases, today announces that they have been able to successfully eliminate Beta Am...

Jackson Center, Pennsylvania--(Newsfile Corp. - January 13, 2022) - Halberd, Corp. (OTC PINK: HALB) ("HALB" or the "Company"), an innovative biotech company focused on developing treatments for difficult-to-cure debilitating diseases, today announces that they have been able to successfully el...

Halberd to bid on Additional Federal Contracts with the Federal Government JACKSON CENTER, PA / ACCESSWIRE / January 5, 2022 / Halberd Corporation (OTC PINK:HALB) is now registered with the Federal Government's System for Award Management allowing Halberd to bid on Federal contracts a...

Latest Testing Eliminates Interleukin-2 From Cerebral Spinal Fluid JACKSON CENTER, PA / ACCESSWIRE / December 20, 2021 / Halberd Corporation (OTC Pink:HALB) has been able to successfully eliminate Interleukin-2 (IL-2) from synthetic cerebral spinal fluid (CSF) in preliminary testing. ...

JACKSON CENTER, PA / ACCESSWIRE / December 15, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-12 (IL-12) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Interleukin-12 is a pro-inflammatory cytokine which has recently been ide...